Table 3.
Factor | PFS | OS | ||
---|---|---|---|---|
p value | HR (95% CI) | p value | HR (95% CI) | |
PD_L1 TPS ≥1% vs. <1% |
0.003 | 0.48 (0.29-0.78) | 0.247 | 0.68 (0.36-1.30) |
Liver Metastasis Yes vs. No |
0.025 | 2.17 (1.10-4.29) | 0.043 | 2.24 (1.03-4.90) |
irAEs Yes vs. No |
0.001 | 0.39 (0.22-0.69) | 0.046 | 0.41 (0.17-0.98) |
CXCL12 Top 1/3 vs. Bottom 2/3 |
4e-04 | 3.01 (1.63-5.55) | 0.001 | 4.63 (1.81-11.80) |
MIF Top 1/3 vs. Bottom 2/3 |
0.915 | 1.03 (0.56-1.90) | 0.079 | 0.42 (0.16-1.10) |
irAE, immune-related adverse events; TPS, tumor proportion score; CI, confidence interval; HR, hazard ratio; the bold values, p < 0.